Lamotrigine-valproic acid combination therapy for medically refractory epilepsy.


PURPOSE A retrospective study of lamotrigine (LTG)-valproic acid (VPA) combination therapy in medically refractory epilepsy. METHODS Patients were identified with an adult epilepsy clinic database and were included if they had been on LTG-VPA combination therapy for at least 6 months. Patient demographics and information about epilepsy type, severity, and… (More)
DOI: 10.1111/j.1528-1167.2008.01866.x